Ginsenoside-Rb3 protects the myocardium from ischemia-reperfusion injury via the inhibition of apoptosis in rats

Experimental and Therapeutic Medicine

Volumn 8, Issue 6, 2014, Pages 1751-1756

  Liu, Xiaomin ^a,b   Jiang, Yichuan ^a   Yu, Xiaofeng ^a   Fu, Wenwen ^a   Zhang, Hong ^a   Sui, Dayun ^a  

^a JILIN UNIVERSITY   (China)

^b Affiliated Hospital of Jilin Medical College   (China)

Author keywords

Apoptosis; Ginsenoside Rb3; Ischemia reperfusion injury; Myocardium

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CREATINE KINASE MB; GINSENOSIDE RB 3; HERBACEOUS AGENT; INTERLEUKIN 6; LACTATE DEHYDROGENASE; MALONALDEHYDE; PLACEBO; PROTEIN BAX; PROTEIN BCL X; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; HEART INFARCTION SIZE; HEART MUSCLE; HEART RATE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; RADIOIMMUNOASSAY; RAT; REPERFUSION INJURY; SPECTROPHOTOMETER; SYSTOLIC BLOOD PRESSURE;

EID: 84908174161     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.2007     Document Type: Article

References (24)

1. Chambless L, Keil U, Dobson A, et al: Population versus clinical view of case fatality from acute coronary heart disease: results from the WHO MONICA Project 1985-1990. Multinational MONItoring of Trends and Determinants in CArdiovascular Disease. Circulation 96: 3849-3859, 1997.
2. Buja LM: Myocardial ischemia and reperfusion injury. Cardiovasc Pathol 14: 170-175, 2005.
3. Yellon DM and Hausenloy DJ: Myocardial reperfusion injury. N Engl J Med 357: 1121-1135, 2007.
4. Fliss H and Gattinger D: Apoptosis in ischemic and reperfused rat myocardium. Circ Res 79: 949-956, 1996.
5. Saraste A, Pulkki K, Kallajoki M, et al: Apoptosis in human acute myocardial infarction. Circulation 95: 320-323, 1997.
6. Haunstetter A and Izumo S: Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ Res 82: 1111-1129, 1998.
7. Xu H, Yu X, Qu S, Chen Y, Wang Z and Sui D: Protective effect of Panax quinquefolium 20(S)-protopanaxadiol saponins, isolated from Panax quinquefolium, on permanent focal cerebral ischemic injury in rats. Exp Ther Med 7: 165-170, 2014.
8. Lin G, Yu X, Wang J, Qu S and Sui D: Beneficial effects of 20(S)-protopanaxadiol on antitumor activity and toxicity of cyclophosphamide in tumor-bearing mice. Exp Ther Med 5: 443-447, 2013.
9. Wang LC and Lee TF: Effect of ginseng saponins on cold tolerance in young and elderly rats. Planta Med 66: 144-147, 2000.
10. Shin JY, Song JY, Yun YS, et al: Immunostimulating effects of acidic polysaccharides extract of Panax ginseng on macrophage function. Immunopharmacol Immunotoxicol 24: 469-482, 2002.
11. Nishijo H, Uwano T, Zhong YM and Ono T: Proof of the mysterious efficacy of ginseng: basic and clinical trials: effects of red ginseng on learning and memory deficits in an animal model of amnesia. J Pharmacol Sci 95: 145-152, 2004.
12. Li G, Wang Z, Sun Y, Liu K and Wang Z: Ginsenoside 20(S)-protopanaxadiol inhibits the proliferation and invasion of human fibrosarcoma HT1080 cells. Basic Clin Pharmacol Toxicol 98: 588-592, 2006.
13. Wang T, Yu X, Qu S, Xu H, Han B and Sui D: Effect of ginsenoside Rb3 on myocardial injury and heart function impairment induced by isoproterenol in rats. Eur J Pharmacol 636: 121-125, 2010.
14. Wang T, Yu XF, Qu SC, Xu HL and Sui DY: Ginsenoside Rb3 inhibits angiotensin II-induced vascular smooth muscle cells proliferation. Basic Clin Pharmacol Toxicol 107: 685-689, 2010.
15. Shi Y, Han B, Yu X, Qu S and Sui D: Ginsenoside Rb3 ameliorates myocardial ischemia-reperfusion injury in rats. Pharm Biol 49: 900-906, 2011.
16. Zhao ZQ, Corvera JS, Halkos ME, et al: Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285: H579-H588, 2003.
17. Nachlas MM and Shnitka TK: Macroscopic identification of early myocardial infarcts by alterations in dehydrogenase activity. Am J Pathol 42: 379-405, 1963.
18. Gupta S: Molecular steps of death receptor and mitochondrial pathways of apoptosis. Life Sci 69: 2957-2964, 2001.
19. Werns SW and Lucchesi BR: Myocardial ischemia and reperfusion: the role of oxygen radicals in tissue injury. Cardiovasc Drugs Ther 2: 761-769, 1989.
20. Bolli R: Oxygen-derived free radicals and postischemic myocardial dysfunction (‘stunned myocardium’). J Am Coll Cardiol 12: 239-249, 1988.
21. Ren G, Dewald O and Frangogiannis NG: Inflammatory mechanisms in myocardial infarction. Curr Drug Targets Inflamm Allergy 2: 242-256, 2003.
22. Frangogiannis NG, Smith CW and Entman ML: The inflammatory response in myocardial infarction. Cardiovasc Res 53: 31-47, 2002.
23. Antonsson B: Bax and other pro-apoptotic Bcl-2 family ‘killer-proteins’ and their victim the mitochondrion. Cell Tissue Res 306: 347-361, 2001.
24. Budihardjo I, Oliver H, Lutter M, Luo X and Wang X: Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 15: 269-290, 1999.